n-acetylneuraminic acid has been researched along with Cardiovascular Diseases in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.06) | 18.7374 |
1990's | 14 (42.42) | 18.2507 |
2000's | 6 (18.18) | 29.6817 |
2010's | 9 (27.27) | 24.3611 |
2020's | 2 (6.06) | 2.80 |
Authors | Studies |
---|---|
Hu, D; Li, C; Wang, DW; Wei, H; Wu, J; Zhao, M; Zheng, L | 1 |
Basaran, O; Dei Giudici, A; Federici, M; Versaci, F | 1 |
Harada, H; Ikeda, H; Kai, H; Katoh, A; Murohara, T; Niiyama, H; Nishiyama, Y; Shibata, R; Yoshida, N | 1 |
Guo, S; Hou, P; Hu, S; Wang, J; Yang, Z; Yin, J; Zhou, G | 1 |
Arıbaş, A; Çiçekler, H; Toker, A; Yerlikaya, FH | 1 |
Aktürk, M; Altay, M; Arslan, M; Ateş, İ; Bukan, N; Çakır, N; Cerit, ET; Karakoç, MA; Yılmaz Demirtaş, C | 1 |
Bictash, M; Brown, IJ; Chadeau-Hyam, M; Chan, Q; Daviglus, ML; De Iorio, M; Ebbels, T; Elliott, P; Garcia-Perez, I; Holmes, E; Kesteloot, H; Loo, RL; Maibaum, E; Nicholson, JK; Stamler, J; Wijeyesekera, A; Yap, IK; Zhao, L | 1 |
Bashir, M; Idrees, M; Khan, RU; Malik, SA; Rahman, IU | 1 |
Ayan, F; Basar, I; Elemek, E; Emekli, N; Emekli-Alturfan, E; Koldas, L; Malali, E; Noyan, U; Oktay, S | 1 |
Amin, F; Idrees, M; Jan, NU; Khan, MI; Khan, RU; Salman, M; ur Rahman, I | 1 |
Franklin, SS; Jendle, J; Jungner, I; Khalili, P; Lundin, F; Nilsson, PM; Sundström, J | 1 |
Ameerally, P; Crook, MA; Goldsmith, L; Lumb, P; Miell, J; Russell-Jones, D; Singh, N | 1 |
MIETTINEN, TA; NIKKILA, EA | 1 |
Afzali, B; Bakri, RS; Bharma-Ariza, P; Covic, A; Crook, MA; Dalton, N; Goldsmith, DJ; Park, WH; Sriharan, M; Sriskantharan, R; Wierzbicki, AS | 1 |
Crook, MA; Gopaul, KP | 1 |
Browning, LM; Jebb, SA; Krebs, JD; Mishra, GD; Moore, CS; O'Connell, MA | 1 |
Akay, H; Altay, M; Duranay, M; Koşar, U; Oztekin, PS; Parpucu, H; Tekeli, N; Yilmaz, FM; Yilmaz, G; Yücel, D | 1 |
Crook, MA; Earle, K; Morocutti, A; Pickup, JC; Viberti, G; Yip, J | 1 |
Alonso, R; Arcocha, V; Arza, MD; Lens, XM; Mouzo, L; Novoa, D; Paz, M; Romero, R; Sanchez-Guisande, D | 1 |
Auersvald, LA; Azhderian, E; Bia, MJ; Friedman, AL; Gruber, J; Lorber, MI; Orias, M; Perez, RV; Sturges, M; Wilson, J | 1 |
Chana, T; Mather, HM; Mattock, MB; Pickup, JC; Samuel, A | 1 |
Chen, J; Deckert, M; Gall, MA; Jensen, JS; Parving, HH; Yokoyama, H | 1 |
Crook, MA; Haq, M; Tutt, P | 1 |
Chusney, GD; Kehely, AM; Mather, HM; Pasapula, C; Pickup, JC; Roberts, GA | 1 |
Collins, D; Crook, M; Fogelman, I; Lumb, P; Treloar, A | 1 |
Andrews, V; Crook, M; Kerai, P; Lumb, P; Swaminathan, R | 1 |
Andrews, V; Crook, M; Lumb, P; Swaminathan, R | 1 |
Abdella, N; Akanji, AO; Al Assoussi, A; Mojiminiyi, OA; Moussa, M | 1 |
Crook, M; Tutt, P | 1 |
Eklund, GA; Gullberg, B; Lindberg, G; Råstam, L; Törnberg, S | 1 |
Eklund, GA; Gullberg, B; Lindberg, G; Råstam, L | 1 |
Corrall, RJ; Flynn, MD; Pennock, CA; Waters, PJ | 1 |
Breidung, R; Hager, K | 1 |
1 review(s) available for n-acetylneuraminic acid and Cardiovascular Diseases
Article | Year |
---|---|
Sialic acid: a novel marker of cardiovascular disease?
Topics: Acute-Phase Reaction; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Chemistry, Clinical; Diabetes Mellitus; Humans; Kidney Diseases; Leukocytes; Metabolic Syndrome; N-Acetylneuraminic Acid; Risk Factors | 2006 |
2 trial(s) available for n-acetylneuraminic acid and Cardiovascular Diseases
Article | Year |
---|---|
A comparison of the effect of glitazones on serum sialic acid in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; N-Acetylneuraminic Acid; Pioglitazone; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2012 |
The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; N-Acetylneuraminic Acid; Obesity; Overweight; Phenotype; Treatment Outcome | 2007 |
30 other study(ies) available for n-acetylneuraminic acid and Cardiovascular Diseases
Article | Year |
---|---|
Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis.
Topics: Antiviral Agents; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; N-Acetylneuraminic Acid; Neuraminidase; Retrospective Studies | 2022 |
Sialic acid: an important contributor to cardiovascular risk.
Topics: Cardiovascular Diseases; Heart Disease Risk Factors; Humans; N-Acetylneuraminic Acid; Risk Factors; Triglycerides | 2021 |
New diagnostic index for sarcopenia in patients with cardiovascular diseases.
Topics: Absorptiometry, Photon; Adiponectin; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Body Mass Index; Cardiovascular Diseases; Female; Hand Strength; Humans; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; N-Acetylneuraminic Acid; Retrospective Studies; Sarcopenia; Sex Factors | 2017 |
Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Cardiovascular Diseases; Cholesterol; Diet, High-Fat; Dietary Supplements; Humans; Lipid Metabolism; Liver; Macrophages; Mice; N-Acetylneuraminic Acid | 2019 |
The association of total sialic acid and malondialdehyde levels with metabolic and anthropometric variables in obesity.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Female; Humans; Insulin Resistance; Male; Malondialdehyde; Middle Aged; N-Acetylneuraminic Acid; Obesity; Risk Factors | 2015 |
Serum Total Sialic Acid Level is Elevated in Hypothyroid Patients as an Atherosclerotic Risk Factor.
Topics: Adolescent; Adult; Atherosclerosis; Autoantibodies; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Humans; Hypothyroidism; Lipoproteins, LDL; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors; Thyroid Hormones; Uric Acid; Young Adult | 2017 |
Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study.
Topics: Adult; Amino Acids, Branched-Chain; Asian People; Biomarkers; Cardiovascular Diseases; China; Creatine; Discriminant Analysis; Female; Geography; Humans; Least-Squares Analysis; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; N-Acetylneuraminic Acid; Risk Assessment; Risk Factors; Succinic Acid; Uromodulin | 2010 |
Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; N-Acetylneuraminic Acid; Risk; Risk Factors; Rosiglitazone; Thiazolidinediones; Triglycerides | 2010 |
Serum and saliva sialic acid in periodontitis patients with and without cardiovascular disease.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Periodontitis; Risk Factors; Saliva | 2010 |
Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individuals.
Topics: Biomarkers; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sweden | 2012 |
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fiji; Glucose Tolerance Test; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors | 2002 |
Serum sialic acid and fucose in myocardial infarction.
Topics: Cardiovascular Diseases; Fucose; Humans; Myocardial Infarction; N-Acetylneuraminic Acid; Neuraminic Acids; Pentoses | 1960 |
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Kidney Transplantation; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors | 2004 |
Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Female; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; N-Acetylneuraminic Acid; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Thiobarbituric Acid Reactive Substances; Tunica Intima; Ultrasonography | 2007 |
Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
Topics: Adult; Albuminuria; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Glomerular Filtration Rate; Humans; Male; N-Acetylneuraminic Acid; Proteinuria; Risk Factors; Sialic Acids; Triglycerides | 1994 |
Sialic acid is a predictor of cardiovascular complications in renal transplantation recipients.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Female; Humans; Kidney Transplantation; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1993 |
Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Kidney Transplantation; N-Acetylneuraminic Acid; Pancreas Transplantation; Risk Factors; Sialic Acids | 1995 |
Serum sialic acid concentrations in Asian diabetic patients in the UK.
Topics: Asia; Biomarkers; Blood Glucose; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Pilot Projects; Reference Values; Risk Factors; Sialic Acids; United Kingdom; White People | 1996 |
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Topics: Aged; Albuminuria; Analysis of Variance; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Electrocardiography; Female; Hemoglobin A; Humans; Lipids; Male; Middle Aged; N-Acetylneuraminic Acid; Prevalence; Reference Values; Risk Factors; Sialic Acids; Smoking | 1996 |
Serum sialic acid and its relationship to various haematological parameters, including erythrocyte sedimentation rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Cell Count; Blood Sedimentation; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid | 1997 |
Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women.
Topics: Acute-Phase Reaction; Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors; Sex Characteristics | 1997 |
The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Humans; Menopause; Middle Aged; N-Acetylneuraminic Acid; Reference Values; Risk Factors | 1998 |
Serum sialic acid, a reputed cardiovascular risk factor, is elevated in South Asian men compared to European men.
Topics: Adult; Asia; Cardiovascular Diseases; Europe; Female; Humans; India; Male; N-Acetylneuraminic Acid; Risk Factors; White People | 1998 |
Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals.
Topics: Adult; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Cholesterol; Female; Humans; Insulin; Lipids; Male; N-Acetylneuraminic Acid; Regression Analysis; Risk Factors; Sex Factors; Statistics, Nonparametric; Triglycerides | 1998 |
Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Electrocardiography; Female; Glycated Hemoglobin; Humans; Kuwait; Lipids; Male; N-Acetylneuraminic Acid; Obesity; Risk Factors; Sex Characteristics; Triglycerides | 2000 |
Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotype.
Topics: Biomarkers; Cardiovascular Diseases; Female; Humans; Hypertriglyceridemia; Lipids; Male; Middle Aged; N-Acetylneuraminic Acid; Phenotype; Risk Factors; Sialic Acids | 1992 |
Serum sialic acid concentration and smoking: a population based study.
Topics: Adult; Aged; Aging; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sex Factors; Sialic Acids; Smoking | 1991 |
Serum sialic acid concentration and cardiovascular mortality.
Topics: Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Confidence Intervals; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Predictive Value of Tests; Prospective Studies; Risk; Risk Factors; Sialic Acids; Sweden | 1991 |
Sialic acid and cardiovascular mortality.
Topics: Cardiovascular Diseases; Humans; N-Acetylneuraminic Acid; Risk Factors; Sialic Acids | 1991 |
[Thrombocytes and aging. Protein and neuraminic acid content of thrombocytes of male donors of various age groups].
Topics: Adult; Aged; Aging; Blood Platelets; Cardiovascular Diseases; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Platelet Aggregation; Platelet Membrane Glycoproteins; Sialic Acids | 1987 |